Prospective randomized trial using cost-utility analysis of early versus delayed laparoscopic cholecystectomy for acute gallbladder disease

Br J Surg. 2009 Sep;96(9):1031-40. doi: 10.1002/bjs.6685.

Abstract

Background: This randomized controlled trial compared the cost-utility of early laparoscopic cholecystectomy with that for conventional management of newly diagnosed acute gallbladder disease.

Methods: Adults admitted to hospital with a first episode of biliary colic or acute cholecystitis were randomized to an early intervention group (36 patients, operation within 72 h of admission) or a conventional group (36, elective cholecystectomy 3 months later). Costs were measured from a National Health Service and societal perspective. Quality-adjusted life year (QALY) gains were calculated 1 month after surgery.

Results: The mean(s.d.) total costs of care were pound 5911(2445) for the early group and pound 6132(3244) for the conventional group (P = 0.928), Mean(s.d.) societal costs were pound 1322(1402) and pound 1461(1532) for the early and conventional groups respectively (P = 0.732). Visual analogue scale scores of health were 72.94 versus 84.63 (P = 0.012) and the mean(s.d.) QALY gain was 0.85(0.26) versus 0.93(0.13) respectively (P = 0.262). The incremental cost per additional QALY gained favoured conventional management at a cost of pound 3810 per QALY gained.

Conclusion: In this pragmatic trial, the cost-utilities of both the early and conventional approaches were similar, but the incremental cost per additional QALY gained favoured conventional management.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biliary Tract Diseases / economics*
  • Biliary Tract Diseases / surgery
  • Cholecystectomy, Laparoscopic / economics*
  • Cholecystitis, Acute / economics*
  • Cholecystitis, Acute / surgery
  • Colic / economics*
  • Colic / surgery
  • Cost-Benefit Analysis
  • Female
  • Health Care Costs
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Quality-Adjusted Life Years
  • Time Factors
  • Treatment Outcome